HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stewart J Tepper Selected Research

erenumab

1/2022Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.
1/2022Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
1/2022Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
10/2021Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.
9/2021Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
7/2021Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
4/2021Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.
1/2021Timing and durability of response to erenumab in patients with chronic migraine.
1/2021Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
1/2020Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stewart J Tepper Research Topics

Disease

111Migraine Disorders (Migraine)
09/2022 - 01/2002
46Headache (Headaches)
03/2022 - 07/2002
31Pain (Aches)
09/2022 - 10/2002
12Nausea
01/2021 - 10/2002
10Epilepsy (Aura)
01/2022 - 10/2002
9Cluster Headache (Cluster Headaches)
03/2022 - 01/2004
8Secondary Headache Disorders
10/2021 - 02/2004
5Headache Disorders (Headache Syndromes)
01/2022 - 06/2002
4Migraine with Aura (Familial Hemiplegic Migraine)
01/2022 - 10/2002
4Migraine without Aura (Common Migraine)
01/2022 - 10/2002
4Hyperacusis (Phonophobia)
07/2018 - 10/2002
4Photophobia (Light Sensitivity)
07/2018 - 10/2002
4Vomiting
09/2013 - 01/2003
4Serotonin Syndrome (Syndrome, Serotonin)
02/2012 - 02/2007
3Hypertension (High Blood Pressure)
10/2021 - 07/2002
3Dysgeusia (Parageusia)
01/2021 - 01/2020
3Dizziness (Lightheadedness)
01/2019 - 11/2011
3Primary Headache Disorders
11/2018 - 09/2008
2Ganglion Cysts (Ganglion)
03/2022 - 07/2013
2Hyperalgesia
09/2013 - 01/2012
2Vascular Diseases (Vascular Disease)
09/2013 - 03/2003
2Tension-Type Headache (Tension Headache)
02/2012 - 10/2008
2Asthma (Bronchial Asthma)
11/2002 - 07/2002
1Mental Disorders (Mental Disorder)
09/2020
1Obesity
09/2020
1Weight Gain
01/2019
1Anxiety Disorders (Anxiety Disorder)
01/2019
1Fatigue
01/2019
1Vertigo (Positional Vertigo)
01/2019
1Prescription Drug Overuse
01/2019
1Paresthesia (Dysesthesia)
01/2018
1Neuralgia (Stump Neuralgia)
01/2018
1Gastroparesis
09/2013

Drug/Important Bio-Agent (IBA)

38Tryptamines (Triptans)IBA
07/2021 - 01/2002
25Pharmaceutical PreparationsIBA
01/2022 - 10/2002
18erenumabIBA
01/2022 - 01/2018
13Monoclonal AntibodiesIBA
03/2022 - 07/2016
13Sumatriptan (Imigran)FDA LinkGeneric
01/2022 - 02/2003
12Calcitonin Gene-Related PeptideIBA
03/2022 - 09/2008
12Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2022 - 09/2008
11Pain-FreeIBA
09/2022 - 10/2011
9Dihydroergotamine (Agit)FDA LinkGeneric
09/2013 - 01/2004
8zolmitriptan (Zomig)FDA Link
01/2022 - 01/2004
8Type A Botulinum Toxins (Botox)FDA Link
09/2021 - 11/2002
8Analgesics (Analgesic Drugs)IBA
01/2020 - 06/2002
7Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
12/2019 - 09/2008
6salicylhydroxamic acid (SHAM)IBA
09/2022 - 06/2009
6galcanezumabIBA
03/2022 - 01/2018
6TabletsIBA
05/2015 - 01/2004
5fremanezumabIBA
03/2022 - 07/2016
5Opioid Analgesics (Opioids)IBA
08/2012 - 05/2006
4Oxygen (Dioxygen)IBA
03/2022 - 10/2017
4eptinezumabIBA
10/2021 - 11/2018
4lasmiditanIBA
08/2021 - 01/2019
4ubrogepantIBA
01/2020 - 11/2018
3LigandsIBA
01/2022 - 05/2017
3SolutionsIBA
01/2021 - 01/2020
3Celecoxib (Celebrex)FDA Link
01/2021 - 01/2020
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020 - 09/2009
3rimegepant sulfateIBA
01/2020 - 11/2018
3PowdersIBA
01/2018 - 05/2015
3MagnesiumIBA
08/2015 - 11/2002
3Riboflavin (Vitamin B2)FDA LinkGeneric
08/2015 - 11/2002
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2013 - 06/2010
3Serotonin (5 Hydroxytryptamine)IBA
01/2013 - 09/2008
3butalbitalFDA LinkGeneric
08/2012 - 05/2009
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2020 - 10/2012
2eletriptan (Relpax)FDA Link
04/2014 - 02/2014
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2013 - 06/2010
2Antidepressive Agents (Antidepressants)IBA
01/2013 - 09/2009
2IronIBA
01/2013 - 02/2012
2Serotonin and Noradrenaline Reuptake InhibitorsIBA
02/2012 - 06/2010
2Ergotamine (Ergotamine Tartrate)FDA LinkGeneric
05/2006 - 02/2003
2naratriptanFDA LinkGeneric
11/2005 - 05/2003
1Prednisone (Sone)FDA LinkGeneric
03/2022
1Octreotide (Sandostatin)FDA LinkGeneric
01/2022
1Nasal SpraysIBA
01/2022
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
01/2022
1DiamondIBA
09/2021
1AntiemeticsIBA
01/2020
1antineoplaston A10 (A 10)IBA
01/2019
1olcegepantIBA
11/2018
1atogepantIBA
11/2018
1Hormones (Hormone)IBA
02/2017
1rizatriptan (Maxalt)FDA Link
02/2017
1Estrogens (Estrogen)FDA Link
02/2017
1Oral ContraceptivesIBA
02/2017
1Dihydrotachysterol (AT 10)IBA
09/2013

Therapy/Procedure

29Therapeutics
09/2022 - 11/2002
7Aftercare (After-Treatment)
09/2022 - 04/2011
6Injections
01/2022 - 01/2004
5Contraindications
09/2013 - 12/2008
3Vagus Nerve Stimulation
03/2022 - 09/2016
3Nerve Block (Nerve Blocks)
07/2013 - 06/2010
2Treatment Delay
09/2020 - 01/2019
1Ambulatory Care (Outpatient Care)
03/2021
1Activities of Daily Living (ADL)
10/2018
1Transcranial Magnetic Stimulation
01/2018
1Ayurvedic Medicine (Siddha Medicine)
06/2014
1Complementary Therapies (Alternative Medicine)
06/2014